Shu utsumi

Dr. Shu utsumi


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2024 in Journal of Neurosurgery
Verified
Journal Article
Closed access
PDF file
SUShu utsumi
Shu utsumi
SOShingo Ohki
Shingo Ohki
NSNobuaki Shime
Nobuaki Shime
OBJECTIVE: The objective of this study was to investigate the epidemiology of moderate traumatic brain injury (TBI) and factors associated with poor neurological outcome. METHODS: This multicenter retrospective cohort study used data from the Japan Trauma Data Bank from 2019 to 2022, including adult patients (aged > 17 years) with moderate TBI (Glasgow Coma Scale [GCS] score of 9–12). Patient characteristics, injury mechanism, details of intracranial injury, treatment, and outcome were investigated. Multivariate mixed-effects logistic regression analysis was used to examine factors associated with poor neurological outcome. Poor neurological outcome was defined as a Glasgow Outcome Scale score ranging between 1 and 3. RESULTS: A total of 1638 patients were included in the study; 67% were male, with a median age of 73 years and a median Injury Severity Score (ISS) of 17. The major mechanism of injury was falls in 545 patients (33%); subdural hematoma and cerebral contusions were both common intracranial injuries in 482 study participants (29%) each. Two hundred forty-seven patients (15%) underwent craniotomy and 366 (22%) were managed with mechanical ventilation. There were 765 patients (47%) with poor neurological outcome, of whom 215 (13%) died in the hospital. Older age (≥ 65 years; adjusted odds ratio [aOR] 4.66, 95% CI 3.54–6.12), higher Charlson Comorbidity Index (CCI; aOR 1.27, 95% CI 1.14–1.42), GCS scores of 9 (aOR 1.50, 95% CI 1.08–2.09) and 10 (aOR 1.37, 95% CI 1.01–1.85), and severe trauma (ISS > 15; aOR 1.93, 95% CI 1.49–2.50) were associated with poor prognosis. Additionally, patients who required mechanical ventilation (aOR 1.76, 95% CI 1.27–2.42) and craniotomy (aOR 1.57, 95% CI 1.08–2.28) had a poor neurological outcome. Administration of tranexamic acid (aOR 0.74, 95% CI 0.58–0.94) and intensive care unit (ICU) admission (aOR 0.69, 95% CI 0.52–0.93) were associated with improved neurological outcome. CONCLUSIONS: Almost half of the patients with moderate TBI had poor neurological outcome at hospital discharge. Several factors including older age, higher CCI, GCS scores of 9 or 10, severe trauma, and mechanical ventilation or craniotomy were found to be associated with poor neurological outcome in patients with moderate TBI. Additionally, these data suggest that tranexamic acid administration and admission to the ICU might be important for improving prognosis. Further investigations are warranted to elucidate the appropriate management for patients with moderate TBI.

2 October 2024 in Annals of Emergency Medicine
Verified
Journal Article
Closed access
SUShu utsumi
Shu utsumi
SOShingo Ohki
Shingo Ohki
SAShunsuke Amagasa
Shunsuke Amagasa
SOShinichiro Ohshimo
Shinichiro Ohshimo
NSNobuaki Shime
Nobuaki Shime

6 December 2024 in Journal of Trauma and Acute Care Surgery
Verified
Journal Article
Closed access
SUShu utsumi
Shu utsumi
AKAkiko Kawakami
Akiko Kawakami
YAYu Amemiya
Yu Amemiya
BACKGROUND Tranexamic acid (TXA) has been used to treat traumatic brain injury (TBI); however, no definitive conclusions have been drawn regarding its effectiveness or dosage. This study evaluated the optimal TXA dose for treating TBI using a network meta-analysis (NMA). METHODS Five databases were searched for peer-reviewed randomized controlled trials (RCTs) published from inception to May 2024. The inclusion criteria were as follows: (1) RCTs, (2) patients older than 1 month with TBI, (3) interventions of TXA and control, (4) primary outcomes of mortality and poor neurological outcomes and secondary outcomes of vascular occlusive events, and (5) full-text peer-reviewed articles. Two reviewers independently screened and extracted the data and assessed the risk of bias. Frequency-based NMA was performed using the Grading of Recommendations, Assessment, Development, and Evaluation working-group approach. RESULTS We included 10 RCTs comprising 11,237 patients with TBI. Placebo showed higher mortality compared with that of a 2-g bolus of TXA (risk ratio, 1.53; 95% confidence interval, 1.08–2.17). Higher mortality was observed with a 1-g bolus of TXA followed by 1-g maintenance TXA compared with that of a 2-g bolus of TXA (risk ratio, 1.44; 95% confidence interval, 1.02–2.03). No significant differences in poor neurological outcomes or vascular occlusive events were observed between the treatment groups. CONCLUSION Placebo and a 1-g bolus followed by 1-g maintenance TXA were associated with higher mortality rates than those of a 2-g bolus of TXA. No difference in vascular occlusive events was observed with either treatment, indicating that our NMA recommends 2 g of TXA. However, the data for the 2-g bolus of TXA were from a single study, and further research is needed to draw definitive conclusions. LEVEL OF EVIDENCE Systematic Review/Meta-Analysis; Level III. Export

1 January 2022 in Neurologia medico-chirurgica
Verified
Journal Article
Open access
PDF file
SUShu utsumi
Shu utsumi
SOShima Ohnishi
Shima Ohnishi
SAShunsuke Amagasa
Shunsuke Amagasa
RSRyuji Sasaki
Ryuji Sasaki
SUSatoko Uematsu
Satoko Uematsu
MKMitsuru Kubota
Mitsuru Kubota
Repeat head computed tomography (RHCT) is common and routine for pediatric traumatic brain injury (TBI) patients. In mild (Glasgow Coma Scale; GCS 13–15) to moderate (GCS 9–12) TBI, recent studies have shown that RHCT without clinical deterioration does not alter management. However, the effectiveness of routine RHCT for pediatric TBI patients under 2 years has not been investigated. This study aims to investigate whether routine RHCT changes management in mild-to-moderate TBI patients under 2 years. We performed a retrospective review at the emergency department of the National Center for Child Health and Development between January 2015 and December 2019. Mild-to-moderate TBI patients under 2 years with an acute intracranial injury on initial head CT scan and receiving follow-up CT scans were included. Mechanism, severity of TBI, indication for RHCT, and their findings were listed. Study outcome was intervention based on the findings of RHCT. Intervention was defined as intubation, ICP monitor placement, or neurosurgery. We identified 50 patients who met inclusion criteria and most patients (48/50) had mild TBI. The most common mechanism was ‘fall’ (68%). Almost all RHCT was routine and the overall incidence of radiographic progression on RHCT was 12%. RHCT without clinical deterioration did not lead to intervention, although one patient with moderate TBI required intervention due to radiographic progression with clinical symptoms. Our study showed that routine RHCT without clinical deterioration for mild TBI patients under 2 years may not alter clinical management. We suggest that RHCT be considered when there is clinical deterioration such as decrease in GCS.

20 January 2023 in World Neurosurgery
Verified
Journal Article
Closed access
SUShu utsumi
Shu utsumi
SAShunsuke Amagasa
Shunsuke Amagasa
HYHideto Yasuda
Hideto Yasuda
TOTakatoshi Oishi
Takatoshi Oishi
MKMasahiro Kashiura
Masahiro Kashiura
TMTakashi Moriya
Takashi Moriya

21 March 2024 in Medicina
Verified
Journal Article
Open access
PDF file
SUShu utsumi
Shu utsumi
MNMitsuaki Nishikimi
Mitsuaki Nishikimi
SOShinichiro Ohshimo
Shinichiro Ohshimo
NSNobuaki Shime
Nobuaki Shime
Out-of-hospital cardiac arrest (OHCA) is heterogeneous in terms of etiology and severity. Owing to this heterogeneity, differences in outcome and treatment efficacy have been reported from case to case; however, few reviews have focused on the heterogeneity of OHCA. We conducted a literature review to identify differences in the prognosis and treatment efficacy in terms of CA-related waveforms (shockable or non-shockable), age (adult or pediatric), and post-CA syndrome severity and to determine the preferred treatment for patients with OHCA to improve outcomes.